This past April marked the 10-year anniversary of the release of the first human genome reference sequence, an epic milestone in the annals of medical science. The use of “first-generation sequencing” required over a decade and almost $3 billion. Today’s NGS technologies can do the same in 3 days for a cost of only $3,000. This represents a remarkable leap in efficiency, making NGS viable even for selected clinical applications. But the real growth in clinical sequencing is yet to come.
4 days ago
Canopy Biosciences exclusively licenses technology for error correction in NGS from Washington University
13 days ago
16 days ago